The Cardiovascular Risk of Proton Pump Inhibitors and the Dangers of Polypharmacy. Malik N, Weintraub WS. Mayo Clin Proc 2021;96:2511-2513.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Malik N, Weintraub WS. The Cardiovascular Risk of Proton Pump Inhibitors and the Dangers of Polypharmacy. Mayo Clin Proc 2021;96:2511-2513.
PMID: 34607632